AB-101 as Monotherapy and With Immunotherapy in Patients With Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma
Clinical trial NCT04673617 · COMPLETED
Trial details
- NCT number
- NCT04673617
- Sponsor
- Artiva Biotherapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-29
- Primary completion
- 2025-10-06
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.